收费全文 | 2549524篇 |
免费 | 200398篇 |
国内免费 | 3979篇 |
耳鼻咽喉 | 36327篇 |
儿科学 | 86578篇 |
妇产科学 | 72100篇 |
基础医学 | 362833篇 |
口腔科学 | 72935篇 |
临床医学 | 225799篇 |
内科学 | 499215篇 |
皮肤病学 | 54856篇 |
神经病学 | 204381篇 |
特种医学 | 101725篇 |
外国民族医学 | 1064篇 |
外科学 | 387960篇 |
综合类 | 59978篇 |
现状与发展 | 4篇 |
一般理论 | 866篇 |
预防医学 | 196989篇 |
眼科学 | 58529篇 |
药学 | 191400篇 |
5篇 | |
中国医学 | 4749篇 |
肿瘤学 | 135608篇 |
2018年 | 24845篇 |
2016年 | 21154篇 |
2015年 | 24238篇 |
2014年 | 33657篇 |
2013年 | 51631篇 |
2012年 | 70138篇 |
2011年 | 74301篇 |
2010年 | 44216篇 |
2009年 | 42088篇 |
2008年 | 71115篇 |
2007年 | 75497篇 |
2006年 | 76366篇 |
2005年 | 74343篇 |
2004年 | 72818篇 |
2003年 | 69990篇 |
2002年 | 68569篇 |
2001年 | 119655篇 |
2000年 | 124168篇 |
1999年 | 105432篇 |
1998年 | 28990篇 |
1997年 | 26271篇 |
1996年 | 26560篇 |
1995年 | 25644篇 |
1994年 | 24174篇 |
1993年 | 22627篇 |
1992年 | 86035篇 |
1991年 | 83905篇 |
1990年 | 82108篇 |
1989年 | 78773篇 |
1988年 | 73061篇 |
1987年 | 71972篇 |
1986年 | 67922篇 |
1985年 | 65485篇 |
1984年 | 49076篇 |
1983年 | 42050篇 |
1982年 | 24666篇 |
1981年 | 22188篇 |
1980年 | 20506篇 |
1979年 | 46003篇 |
1978年 | 32089篇 |
1977年 | 27055篇 |
1976年 | 25473篇 |
1975年 | 27180篇 |
1974年 | 32728篇 |
1973年 | 31535篇 |
1972年 | 29007篇 |
1971年 | 26886篇 |
1970年 | 24990篇 |
1969年 | 23207篇 |
1968年 | 21201篇 |
Background
Post-stroke dysphagia is characterized by reduced corticolingual excitability and lingual pressure; however, it remains unknown if transcranial magnetic stimulation (TMS) directly facilitates lingual pressure generation. 相似文献Objectives
Triazole resistance in Aspergillus spp. is emerging and complicates prophylaxis and treatment of invasive aspergillosis (IA) worldwide. New polymerase chain reaction (PCR) tests on broncho-alveolar lavage (BAL) fluid allow for detection of triazole resistance at a genetic level, which has opened up new possibilities for targeted therapy. In the absence of clinical trials, a modelling study delivers estimates of the added value of resistance detection with PCR, and which empiric therapy would be optimal when local resistance rates are known.Design
A decision-analytic modelling study was performed based on epidemiological data of IA, extended with estimated dynamics of resistance rates and treatment effectiveness. Six clinical strategies were compared that differ in use of PCR diagnostics (used vs not used) and in empiric therapeutic choice in case of unknown triazole susceptibility: voriconazole, liposomal amphotericin B (LAmB) or both. Outcome measures were proportion of correct treatment, survival and serious adverse events.Results
Implementing aspergillus PCR tests was projected to result in residual treatment-susceptibility mismatches of <5% for a triazole resistance rate up to 20% (using voriconazole). Empiric LAmB outperformed voriconazole at resistance rates >5–20%, depending on PCR use and estimated survival benefits of voriconazole over LAmB. Combination therapy of voriconazole and LAmB performed best at all resistance rates, but the advantage over the other strategies should be weighed against the expected increased number of drug-related serious adverse events. The advantage of combination therapy over LAmB monotherapy became smaller at higher triazole resistance rates.Conclusions
Introduction of current aspergillus PCR tests on BAL fluid is an effective way to increase the proportion of patients that receive targeted therapy for IA. The results indicate that close monitoring of background resistance rates and adverse drug events are important to attain the potential benefits of LAmB. The choice of strategy ultimately depends on the probability of triazole resistance, the availability of PCR and individual patient characteristics. 相似文献Methods: This retrospective, non-randomized, interventional comparative study included 38 eyes of 38 patients. All cases underwent PPV with silicone oil tamponade. The main outcome measure was improvement of final visual acuity relative to the presenting visual acuity and factors affecting the same Group A included eyes with favorable vision of 20/400 or better and Group B included the others.
Results: Group A included 16 eyes (42.10%), group B included 22 eyes (57.89%). In Group A 2 eyes out of 16 (12.5%) and in Group B 12 eyes out of 22 (54.54%) had RRD at presentation (p = 0.02, 95% CI for the difference 7.88–65.78%). The time interval between first presentation and development of RRD in Group A was 30.94 ± 38.8 days (median 30 days) whereas that in Group B was 10.81 ± 11.73 days (median 8 days) (p = 0.02). The odds of visual improvement post-vitrectomy when RRD occurred later was 8.4 (p = 0.01, 95% CI 1.53–46.1). The usage of systemic steroids (odds 5.2, p = 0.03, 95% CI 1.14–23.54) and oral valacyclovir (odds 4.33, p = 0.04, 95% CI 1.05–17.84) were associated with odds favoring a good visual outcome. Recurrent RRD was noted in 3/16 eyes (18.75%) in Group A and 13/22 eyes (59.09%) in Group B (p = 0.03).
Conclusion: Delayed occurrence of RRD after ARN is a good prognostic factor. Usage of systemic steroids and oral valacylocvir are associated with a favorable visual outcome when started before the onset of RRD. 相似文献
Prolonged mechanical ventilation (MV) is a major complication following cardiac surgery. We conducted a secondary analysis of the Transfusion Requirements in Cardiac Surgery (TRICTS) III trial to describe MV duration, identify factors associated with prolonged MV, and examine associations of prolonged MV with mortality and complications.
MethodsFour thousand, eight hundred and nine participants undergoing cardiac surgery at 71 hospitals worldwide were included. Prolonged MV was defined based on the Society of Thoracic Surgeons definition as MV lasting 24 hr or longer. Adjusted associations of patient and surgical factors with prolonged MV were examined using multivariable logistic regression. Associations of prolonged MV with complications were assessed using odds ratios, and adjusted associations between prolonged MV and mortality were evaluated using multinomial regression. Associations of shorter durations of MV with survival and complications were explored.
ResultsProlonged MV occurred in 15% (725/4,809) of participants. Prolonged MV was associated with surgical factors indicative of complexity, such as previous cardiac surgery, cardiopulmonary bypass duration, and separation attempts; and patient factors such as critical preoperative state, left ventricular impairment, renal failure, and pulmonary hypertension. Prolonged MV was associated with perioperative but not long-term complications. After risk adjustment, prolonged MV was associated with perioperative mortality; its association with long-term mortality among survivors was weaker. Shorter durations of MV were not associated with increased risk of mortality or complications.
ConclusionIn this substudy of the TRICS III trial, prolonged MV was common after cardiac surgery and was associated with patient and surgical risk factors. Although prolonged MV showed strong associations with perioperative complications and mortality, it was not associated with long-term complications and had weaker association with long-term mortality among survivors.
Study registrationwww.ClinicalTrials.gov (NCT02042898); registered 23 January 2014. This is a substudy of the Transfusion Requirements in Cardiac Surgery (TRICS) III trial.
相似文献- Improve the accuracy of commonly quoted COVID-19 mortality indicators;
- Gain a better understanding of spatial and temporal distribution of COVID-19 deaths;
- Examine the role of race, ethnicity, and socioeconomic status in COVID-19 mortality;
- Identify population and organizational parameters that can inform strategies for public health interventions.